Vanda Pharmaceuticals Inc.

VNDA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001347178

SEC filings (opens in a new tab)

No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Vanda Pharmaceuticals Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of VNDA: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	178	1	190	+13
Shares	55.1M	1.34K	55.5M	+416.5K (+0.8%)
Value	$544.1M	$13.0K	$410.0M	−$134.1M (−24.6%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to VNDA in Q4 2022
Institution	Shares	Value	% of portfolio
Bridgeway Capital Management, LLC	325,600	$2.41M	0.06%
Foundry Partners, LLC	282,268	$2.09M	0.12%
Norges Bank	159,000	$1.18M	0.00%
Brandywine Global Investment Management, LLC	148,219	$1.10M	0.01%
Walleye Capital LLC	147,040	$1.09M	0.02%
Y-Intercept (Hong Kong) Ltd	58,081	$429.2K	0.06%
Qube Research & Technologies Ltd	57,042	$421.5K	0.00%
Exchange Traded Concepts, LLC	55,749	$412.0K	0.01%
Seizert Capital Partners, LLC	48,244	$356.5K	0.02%
XTX Topco Ltd	46,702	$345.1K	0.07%
Engineers Gate Manager LP	38,186	$282.2K	0.02%
Prelude Capital Management, LLC	23,776	$175.7K	0.01%
Maryland State Retirement & Pension System	23,138	$171.0K	0.01%
Squarepoint Ops LLC	15,119	$111.7K	0.00%
Legato Capital Management LLC	14,778	$109.2K	0.02%
Wedge Capital Management L L P	11,004	$81.0K	0.00%
Virtus Investment Advisers, Inc.	10,908	$80.6K	0.05%
Tudor Investment Corp Et Al	10,740	$79.0K	0.00%
HSBC Holdings PLC	10,548	$77.6K	0.00%
Capital Advisors, Ltd. LLC	5,000	$37.0K	0.01%
Altshuler Shaham Ltd	2,451	$18.1K	0.00%
TCI Wealth Advisors, Inc.	660	$4.88K	0.00%
Heritage Wealth Advisors	300	$2.22K	0.00%
Farther Finance Advisors, LLC	206	$1.52K	0.00%
Fifth Third Bancorp	112	$828	0.00%
Clearstead Advisors, LLC	50	$370	0.00%
Glassman Wealth Services	49	$362	0.00%
Money Concepts Capital Corp	7	$52	0.00%
Private Trust Co NA	20	$0	0.00%

Sold out (16)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of VNDA in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Tang Capital Management LLC	256,696	$2.54M
Occudo Quantitative Strategies LP	65,773	$650.0K
Schonfeld Strategic Advisors LLC	49,991	$494.0K
TD Asset Management Inc	26,781	$262.0K
PDT Partners, LLC	20,065	$198.0K
Zebra Capital Management LLC	14,975	$148.0K
Algert Global LLC	11,830	$117.0K
MQS Management LLC	10,488	$104.0K
ExodusPoint Capital Management, LP	10,099	$100.0K
Quantbot Technologies LP	9,200	$90.0K
North Star Investment Management Corp.	3,000	$30.0K
Allworth Financial LP	1,234	$12.0K
TD Waterhouse Canada Inc.	503	$5.08K
Meeder Asset Management Inc	154	$2.00K
Massmutual Trust Co FSB	85	$1.00K
Signaturefd, LLC	71	$1.00K

Not filed for Q4 2022 yet (1)

Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VNDA in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Wipfli Financial Advisors LLC,	1,342	$13.0K